🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of Tylenol, asserting the corporations withheld safety concerns that the drug posed to pediatric brain development.

This legal action follows thirty days after President Donald Trump advocated an unsubstantiated connection between consuming Tylenol - alternatively called paracetamol - throughout gestation and autism in young ones.

The attorney general is suing the pharmaceutical giant, which previously sold the drug, the only pain reliever approved for women during pregnancy, and Kenvue, which presently makes it.

In a declaration, he claimed they "misled consumers by making money from discomfort and marketing drugs ignoring the dangers."

Kenvue states there is lacking scientific proof connecting Tylenol to autism.

"These manufacturers lied for decades, intentionally threatening countless individuals to boost earnings," the attorney general, from the Republican party, declared.

The company stated officially that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the welfare of American women and children."

On its website, Kenvue also stated it had "regularly reviewed the applicable studies and there is lacking reliable evidence that indicates a proven link between taking paracetamol and autism spectrum disorder."

Organizations speaking for doctors and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the main ingredient in acetaminophen - is a restricted selection for pregnant women to manage discomfort and elevated temperature, which can create significant medical dangers if left untreated.

"In over twenty years of investigation on the consumption of paracetamol in gestation, no reliable research has definitively established that the use of paracetamol in any trimester of pregnancy leads to brain development issues in young ones," the organization said.

The lawsuit cites recent announcements from the former administration in asserting the medication is reportedly hazardous.

In recent weeks, Trump raised alarms from public health officials when he advised expectant mothers to "struggle intensely" not to take Tylenol when ill.

The US Food and Drug Administration then published an announcement that medical professionals should consider limiting the usage of acetaminophen, while also declaring that "a direct connection" between the drug and autism in minors has not been proven.

The Health Department head RFK Jr, who oversees the FDA, had pledged in April to initiate "a massive testing and research effort" that would establish the cause of autism in a limited time.

But specialists cautioned that finding a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism spectrum disorder is a form of enduring cognitive variation and impairment that affects how individuals perceive and engage with the world, and is identified using doctors' observations.

In his lawsuit, Paxton - a Trump ally who is seeking US Senate - asserts Kenvue and Johnson & Johnson "willfully ignored and sought to suppress the science" around paracetamol and autism spectrum disorder.

The case aims to force the corporations "eliminate any marketing or advertising" that claims Tylenol is secure for women during pregnancy.

The court case mirrors the grievances of a assembly of parents of young ones with autism spectrum disorder and ADHD who took legal action against the producers of Tylenol in recently.

The court threw out the lawsuit, declaring studies from the family's specialists was lacking definitive proof.